These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21502993)

  • 1. Rethinking the metastatic cascade as a therapeutic target.
    Mina LA; Sledge GW
    Nat Rev Clin Oncol; 2011 Jun; 8(6):325-32. PubMed ID: 21502993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metastatic spread: mechanisms and therapies].
    Perret GY
    J Soc Biol; 2007; 201(3):237-41. PubMed ID: 18157075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer metastasis: a search for therapeutic inhibition.
    Dimitroff CJ; Sharma A; Bernacki RJ
    Cancer Invest; 1998; 16(4):279-90. PubMed ID: 9589037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and clinical importance of micrometastatic disease.
    Pantel K; Cote RJ; Fodstad O
    J Natl Cancer Inst; 1999 Jul; 91(13):1113-24. PubMed ID: 10393719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting Tumor Metastases: The Road to Therapy Starts Here.
    Menezes ME; Das SK; Minn I; Emdad L; Wang XY; Sarkar D; Pomper MG; Fisher PB
    Adv Cancer Res; 2016; 132():1-44. PubMed ID: 27613128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacological strategies against metastatic spread.
    Perret GY; Crépin M
    Fundam Clin Pharmacol; 2008 Oct; 22(5):465-92. PubMed ID: 18844722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents.
    Fouani L; Menezes SV; Paulson M; Richardson DR; Kovacevic Z
    Pharmacol Res; 2017 Jan; 115():275-287. PubMed ID: 27940016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targets for metastatic prostate cancer.
    Timme TL; Satoh T; Tahir SA; Wang H; Teh BS; Butler EB; Miles BJ; Amato RJ; Kadmon D; Thompson TC
    Curr Drug Targets; 2003 Apr; 4(3):251-61. PubMed ID: 12643475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic modulation of prostate cancer metastasis.
    Krishna SN; Bergan RC
    Future Med Chem; 2014 Feb; 6(2):223-39. PubMed ID: 24467245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment.
    Epstein RJ
    Clin Cancer Res; 2005 Aug; 11(15):5337-41. PubMed ID: 16061845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities.
    Shen M; Kang Y
    Genes Dev; 2020 Dec; 34(23-24):1577-1598. PubMed ID: 33262145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic niche functions and therapeutic opportunities.
    Celià-Terrassa T; Kang Y
    Nat Cell Biol; 2018 Aug; 20(8):868-877. PubMed ID: 30050120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumour cells--a bona fide cause of metastatic cancer.
    Caixeiro NJ; Kienzle N; Lim SH; Spring KJ; Tognela A; Scott KF; de Souza P; Becker TM
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):747-56. PubMed ID: 24817039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cytoskeleton reorganisation as antimetastatic treatment.
    Quintela-Fandino M; González-Martín A; Colomer R
    Clin Transl Oncol; 2010 Oct; 12(10):662-9. PubMed ID: 20947480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Regulation of the Metastatic Process: Implications for Therapy.
    de Mingo Pulido A; Ruffell B
    Adv Cancer Res; 2016; 132():139-63. PubMed ID: 27613132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future approaches for the therapeutic targeting of metastasis (review).
    Germanov E; Berman JN; Guernsey DL
    Int J Mol Med; 2006 Dec; 18(6):1025-36. PubMed ID: 17089005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targets for antimetastatic therapy.
    Hedley BD; Winquist E; Chambers AF
    Expert Opin Ther Targets; 2004 Dec; 8(6):527-36. PubMed ID: 15584860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.